Stock IMVT IMMUNOVANT, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Immunovant, Inc.

Equities

IMVT

US45258J1025

Real-time Estimate Cboe BZX
Other stock markets
 10:38:11 2024-06-10 am EDT 		5-day change 1st Jan Change
25.02 USD -0.58% Intraday chart for Immunovant, Inc. -1.35% -40.99%
Jun. 03 Oppenheimer Adjusts Immunovant Price Target to $46 From $50, Maintains Outperform Rating MT
May. 30 Sector Update: Health Care Stocks Mixed Pre-Bell Thursday MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oppenheimer Adjusts Immunovant Price Target to $46 From $50, Maintains Outperform Rating
MT
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday
MT
Immunovant Q4 Loss Widens -- Shares Fall After-Hours
MT
Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024
AQ
Immunovant, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Immunovant, Inc. Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Immunovant Insider Sold Shares Worth $479,233, According to a Recent SEC Filing
MT
Immunovant Insider Sold Shares Worth $990,269, According to a Recent SEC Filing
MT
Immunovant Insider Sold Shares Worth $293,923, According to a Recent SEC Filing
MT
Oppenheimer Initiates Coverage on Immunovant With Outperform Rating, $50 Price Target
MT
Goldman Sachs Starts Coverage on Immunovant With Buy Rating, $50 Price Target
MT
Immunovant Awarded U.S. Patent for IMVT-1402
AQ
Immunovant Insider Sold Shares Worth $486,362, According to a Recent SEC Filing
MT
JPMorgan Starts Coverage on Immunovant With Overweight Rating, $51 Price Target
MT
Wolfe Research Starts Immunovant With Outperform Rating, $55 Price Target
MT
Immunovant Posts Narrower Fiscal Q3 Loss
MT
Immunovant, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended December 31, 2023
AQ
North American Morning Briefing : Stock Futures -2-
DJ
North American Morning Briefing : Jobs Report Tops -2-
DJ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMVT Stock
  4. News Immunovant, Inc.